Market closed
GeoVax Labs Inc./$GOVX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
Ticker
$GOVX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
17
ISIN
US3736786068
Website
GeoVax Labs Inc. Metrics
BasicAdvanced
$14M
-
-$3.23
-
-
Price and volume
Market cap
$14M
52-week high
$1.89
52-week low
$0.73
Average daily volume
398K
Financial strength
Interest coverage (TTM)
-1,153.98%
Management effectiveness
Return on assets (TTM)
-915.19%
Return on equity (TTM)
-78,814.57%
Valuation
Price to revenue (TTM)
1.336
Price to book
1,492.12
Price to tangible book (TTM)
1,492.12
Growth
Earnings per share change (TTM)
-77.09%
3-year revenue growth (CAGR)
150.29%
3-year earnings per share growth (CAGR)
-58.30%
GeoVax Labs Inc. News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for GeoVax Labs Inc. stock?
GeoVax Labs Inc. (GOVX) has a market cap of $14M as of May 18, 2025.
What is the P/E ratio for GeoVax Labs Inc. stock?
The price to earnings (P/E) ratio for GeoVax Labs Inc. (GOVX) stock is 0 as of May 18, 2025.
Does GeoVax Labs Inc. stock pay dividends?
No, GeoVax Labs Inc. (GOVX) stock does not pay dividends to its shareholders as of May 18, 2025.
When is the next GeoVax Labs Inc. dividend payment date?
GeoVax Labs Inc. (GOVX) stock does not pay dividends to its shareholders.
What is the beta indicator for GeoVax Labs Inc.?
GeoVax Labs Inc. (GOVX) does not currently have a Beta indicator.